The management of neoplastic colorectal obstruction with colonic endolumenal stenting devices

Guy J.C. Harris, Anthony J. Senagore, Ian C. Lavery, Victor W. Fazio

    Research output: Contribution to journalArticlepeer-review

    102 Scopus citations


    Background: Colonic endolumenal stenting (CELS) to treat obstructing colorectal neoplasms was first described in 1991. The aim of this study was to review the published world literature and make recommendations for its use in current clinical practice. Methods: Suitable English language reports were identified using a Medline search. Results: CELS can been successfully accomplished in 64% to 100% of obstructing malignant colonic lesions. Distal lesions are more common and theoretically more easy to stent although lesions within the ascending colon have been successfully managed. Minor complications include transient anorectal pain and rectal bleeding, however, significant complications of stent dislocation and colonic perforation are also well recognized. Conclusion: CELS can aid the palliative management of malignant colorectal obstruction. Its role in relieving obstruction prior to resection remains to be defined. Increasing experience has allowed the safe placement of stents and relief of obstruction of virtually any lesion throughout the large bowel.

    Original languageEnglish (US)
    Pages (from-to)499-506
    Number of pages8
    JournalAmerican Journal of Surgery
    Issue number6
    StatePublished - 2001


    • Colorectal cancer
    • Endoscopy
    • Stents

    ASJC Scopus subject areas

    • Surgery


    Dive into the research topics of 'The management of neoplastic colorectal obstruction with colonic endolumenal stenting devices'. Together they form a unique fingerprint.

    Cite this